Arthur has more than 3 years of venture capital experience, across multiple industries and stages, with a particular interest in healthcare and life sciences. In his prior role as part of the Helvetica Capital deal team, Arthur was especially involved in all topics around the Swiss Entrepreneurs Fund and the ever-green investment vehicle Credit Suisse Entrepreneur Capital.
Before joining Helvetica Capital, Arthur spent a summer at McKinsey & Company, where he worked on multiple projects within the pharmaceutical industry.
He holds degrees in Biology (B.Sc.) and a joint degree in Microbiology and Immunology (M.Sc.) from the Swiss Federal Institute of Technology (ETH Zürich), including an academic exchange at the University of Oxford.